NCT00849797View on ClinicalTrials.gov

Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

Oxcarbazepine

600 mg Tablet

DRUG

Trileptal®

600 mg Tablet

Trial Locations (1)

H3X 2H9

SFBC Anapharm, Montreal

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00849797 - Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter